OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
Navonil De Sarkar, Robert D. Patton, Anna-Lisa Doebley, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 632-653
Open Access | Times Cited: 34
Navonil De Sarkar, Robert D. Patton, Anna-Lisa Doebley, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 632-653
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Liquid biopsy epigenomic profiling for cancer subtyping
Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2737-2741
Open Access | Times Cited: 43
Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2737-2741
Open Access | Times Cited: 43
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 40
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 40
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Cancer Discovery (2023) Vol. 14, Iss. 3, pp. 424-445
Open Access | Times Cited: 23
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, et al.
Cancer Discovery (2023) Vol. 14, Iss. 3, pp. 424-445
Open Access | Times Cited: 23
Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution
Irene Casanova‐Salas, Daniel Aguilar, Sarai Córdoba-Terreros, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1301-1312.e7
Open Access | Times Cited: 9
Irene Casanova‐Salas, Daniel Aguilar, Sarai Córdoba-Terreros, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1301-1312.e7
Open Access | Times Cited: 9
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions
Joseph B. Hiatt, Anna-Lisa Doebley, Henry U. Arnold, et al.
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 8
Joseph B. Hiatt, Anna-Lisa Doebley, Henry U. Arnold, et al.
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 8
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
Preeclampsia risk prediction from prenatal cell-free DNA screening
Mohamed Adil, Teodora Kolarova, Anna-Lisa Doebley, et al.
Nature Medicine (2025)
Open Access
Mohamed Adil, Teodora Kolarova, Anna-Lisa Doebley, et al.
Nature Medicine (2025)
Open Access
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis
Norbert Moldován, Ymke van der Pol, Tom van den Ende, et al.
Cell Reports Medicine (2023) Vol. 5, Iss. 1, pp. 101349-101349
Open Access | Times Cited: 16
Norbert Moldován, Ymke van der Pol, Tom van den Ende, et al.
Cell Reports Medicine (2023) Vol. 5, Iss. 1, pp. 101349-101349
Open Access | Times Cited: 16
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
Cameron Herberts, Alexander W. Wyatt, Paul L. Nguyen, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 14
Cameron Herberts, Alexander W. Wyatt, Paul L. Nguyen, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 14
Epigenetic Alterations That Are the Backbone of Immune Evasion in T-cell Malignancies
Mihaela Andreescu
Cureus (2024)
Open Access | Times Cited: 5
Mihaela Andreescu
Cureus (2024)
Open Access | Times Cited: 5
Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA
Xu Hua, Hui Zhou, Hui‐Chen Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Xu Hua, Hui Zhou, Hui‐Chen Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling
Talal El Zarif, Catherine B. Meador, Xintao Qiu, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3798-3811
Open Access | Times Cited: 3
Talal El Zarif, Catherine B. Meador, Xintao Qiu, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3798-3811
Open Access | Times Cited: 3
The future of patient-derived xenografts in prostate cancer research
Mitchell G. Lawrence, Renea A. Taylor, Georgia B. Cuffe, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 6, pp. 371-384
Open Access | Times Cited: 8
Mitchell G. Lawrence, Renea A. Taylor, Georgia B. Cuffe, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 6, pp. 371-384
Open Access | Times Cited: 8
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma
Talal El Zarif, Karl Semaan, Marc Eid, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114350-114350
Open Access | Times Cited: 2
Talal El Zarif, Karl Semaan, Marc Eid, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114350-114350
Open Access | Times Cited: 2
Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
Shouyi Zhang, Tao Shen, Yu Zeng
Cancers (2023) Vol. 15, Iss. 8, pp. 2243-2243
Open Access | Times Cited: 6
Shouyi Zhang, Tao Shen, Yu Zeng
Cancers (2023) Vol. 15, Iss. 8, pp. 2243-2243
Open Access | Times Cited: 6
Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery
Lucas Penny, Sasha Main, Steven De Michino, et al.
Biochemistry and Cell Biology (2024) Vol. 102, Iss. 4, pp. 291-298
Open Access | Times Cited: 1
Lucas Penny, Sasha Main, Steven De Michino, et al.
Biochemistry and Cell Biology (2024) Vol. 102, Iss. 4, pp. 291-298
Open Access | Times Cited: 1
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Sophia C. Kamran, Tamara Jamaspishvili, et al.
The Prostate (2024) Vol. 84, Iss. 11, pp. 993-1015
Closed Access | Times Cited: 1
Andrea K. Miyahira, Sophia C. Kamran, Tamara Jamaspishvili, et al.
The Prostate (2024) Vol. 84, Iss. 11, pp. 993-1015
Closed Access | Times Cited: 1
Circulating tumor cell characterization and classification by novel combinatorial dual-color (CoDuCo) in situ hybridization and supervised machine learning
Lilli Bonstingl, Margret Zinnegger, Katja Sallinger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lilli Bonstingl, Margret Zinnegger, Katja Sallinger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mining nucleic acid “omics” to boost liquid biopsy in cancer
Ann Tivey, Rebecca Lee, Alexandra Clipson, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101736-101736
Open Access | Times Cited: 1
Ann Tivey, Rebecca Lee, Alexandra Clipson, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101736-101736
Open Access | Times Cited: 1
LBFextract: unveiling transcription factor dynamics from liquid biopsy data
Isaac Lazzeri, Benjamin Spiegl, Samantha O. Hasenleithner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Isaac Lazzeri, Benjamin Spiegl, Samantha O. Hasenleithner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor
Yulin Wu, Yan‐Fang Xian, Juan Zhang, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 3
Closed Access
Yulin Wu, Yan‐Fang Xian, Juan Zhang, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 3
Closed Access
LBFextract: Unveiling transcription factor dynamics from liquid biopsy data
Isaac Lazzeri, Benjamin Spiegl, Samantha O. Hasenleithner, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3163-3174
Open Access
Isaac Lazzeri, Benjamin Spiegl, Samantha O. Hasenleithner, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3163-3174
Open Access
Application of Biomechanics in Tumor Epigenetic Research
Qi Wang, Yin Xiao, Yunyi Ding, et al.
Mechanobiology in Medicine (2024) Vol. 2, Iss. 4, pp. 100093-100093
Open Access
Qi Wang, Yin Xiao, Yunyi Ding, et al.
Mechanobiology in Medicine (2024) Vol. 2, Iss. 4, pp. 100093-100093
Open Access
CDHu40: a novel marker gene set of neuroendocrine prostate cancer
Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access
Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access
Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis
Yue Gao, Shanpeng Zhang, Xianhong Zhang, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111359-111359
Open Access
Yue Gao, Shanpeng Zhang, Xianhong Zhang, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111359-111359
Open Access
